| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |